IDEX Emisjon satt, 2,85NOK, hentet 30MUSD
Oslo, 9 November 2021.
IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint identification and authentications solutions, has retained Arctic Securities AS as sole manager and bookrunner (the "Manager") to advise on and effect a private placement (the "Private Placement") of new shares in the Company (the "Offer Shares") to raise gross proceeds of up to the NOK equivalent of USD 25 million.
The net proceeds from the Private Placement will be used to cover the forecasted cash requirements until the point of cashflow break even as well as for general corporate purposes.
The following primary insiders and senior management have pre-committed to subscribe for Offer Shares in the Private Placement:
* Vincent Arthur Graziani (CEO) has pre-committed to subscribe for Offer Shares for a total value equal to the NOK equivalent of USD 50,000.
* Jamie Simms (CFO) has pre-committed to subscribe for Offer Shares for a total value equal to the NOK equivalent of USD 500,000.
* Annika Olsson (Board member) has pre-committed to subscribe for a total value equal of NOK 150,000.
* Skorpion AS, a company closely related to Marianne Bøe (Investor Relations) has pre-committed to subscribe for Offer Shares for a total value of NOK 1,000,000.
* Erling Svela (VP Finance) has pre-committed to subscribe for Offer Shares for a total value equal of NOK 150,000.
The subscription price per Offer Share (the "Offer Price") and the number of Offer Shares to be issued in the Private Placement will be determined by the board of directors of the Company (the "Board") following an accelerated bookbuilding process. The bookbuilding period commences today at 16:30 CET and ends at 08:00 CET on 10 November 2021. The bookbuilding period may, at the discretion of the Company and the Manager, close earlier or later and may be cancelled at any time and, consequently, the Company may refrain from completing the Private Placement.
The Company will announce the final number of Offer Shares placed and the final Offer Price in a stock exchange announcement expected to be published later today or before the opening of trading on the Oslo Stock Exchange tomorrow, 10 November 2021.
The Private Placement will be directed towards Norwegian and international investors, in each case subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000, provided that the Company may, at its sole discretion, allocate an amount below EUR 100,000 to the extent applicable exemptions from relevant prospectus and registration requirements pursuant to applicable regulations, including the Norwegian Securities Trading Act and ancillary regulations, are available.
The allocation of Offer Shares will be made at the sole discretion of the Board after input from the Manager. Allocation will be based on criteria such as (but not limited to), existing ownership in the Company, timeliness of the application, price leadership, relative order size, sector knowledge, investment history, perceived investor quality and investment horizon. The Board may, at its sole discretion, reject and/or reduce any applications. There is no guarantee that any applicant will be allocated Offer Shares. The allocation will be determined at the end of the bookbuilding period and final allocation will be made at the Board's sole discretion. Notification of allotment and payment instructions are expected to be issued to the applicants on or about 10 November 2021 through a notification to be issued by the Manager.
Settlement is expected to take place on or about 12 November 2021 on a delivery versus payment basis. The Offer Shares are expected to be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement expected to be entered into between certain existing shareholders, the Manager and the Company, in order to facilitate delivery of already listed shares in the Company to applicants (the "Share Lending Agreement"). The Offer Shares will thus be tradable from allocation. The share loan will be settled with new shares in the Company to be resolved issued by the Board pursuant to an authorization granted by the Company's annual general meeting held on 12 May 2021.
The Company reserves the right, at any time and for any reason, to cancel, and/or modify the terms of, the Private Placement prior to completion. Neither the Company nor the Manager will be liable for any losses incurred by applicants if the Private Placement is cancelled, irrespective of the reason for such cancellation.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it will be in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the growth opportunities currently available to the Company. A private placement enables the Company to raise capital in an efficient manner, and the Private Placement is structured to ensure that a market-based subscription price is achieved. By structuring the equity raise as a private placement, the Company is expected to be in a position to raise capital at a better share price, at a lower cost and with significantly lower risk than in a rights issue.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Erling Svela, VP Finance on 9 November 2021 at 16:30 CET on behalf of the Company.
IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint identification and authentications solutions, has retained Arctic Securities AS as sole manager and bookrunner (the "Manager") to advise on and effect a private placement (the "Private Placement") of new shares in the Company (the "Offer Shares") to raise gross proceeds of up to the NOK equivalent of USD 25 million.
The net proceeds from the Private Placement will be used to cover the forecasted cash requirements until the point of cashflow break even as well as for general corporate purposes.
The following primary insiders and senior management have pre-committed to subscribe for Offer Shares in the Private Placement:
* Vincent Arthur Graziani (CEO) has pre-committed to subscribe for Offer Shares for a total value equal to the NOK equivalent of USD 50,000.
* Jamie Simms (CFO) has pre-committed to subscribe for Offer Shares for a total value equal to the NOK equivalent of USD 500,000.
* Annika Olsson (Board member) has pre-committed to subscribe for a total value equal of NOK 150,000.
* Skorpion AS, a company closely related to Marianne Bøe (Investor Relations) has pre-committed to subscribe for Offer Shares for a total value of NOK 1,000,000.
* Erling Svela (VP Finance) has pre-committed to subscribe for Offer Shares for a total value equal of NOK 150,000.
The subscription price per Offer Share (the "Offer Price") and the number of Offer Shares to be issued in the Private Placement will be determined by the board of directors of the Company (the "Board") following an accelerated bookbuilding process. The bookbuilding period commences today at 16:30 CET and ends at 08:00 CET on 10 November 2021. The bookbuilding period may, at the discretion of the Company and the Manager, close earlier or later and may be cancelled at any time and, consequently, the Company may refrain from completing the Private Placement.
The Company will announce the final number of Offer Shares placed and the final Offer Price in a stock exchange announcement expected to be published later today or before the opening of trading on the Oslo Stock Exchange tomorrow, 10 November 2021.
The Private Placement will be directed towards Norwegian and international investors, in each case subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000, provided that the Company may, at its sole discretion, allocate an amount below EUR 100,000 to the extent applicable exemptions from relevant prospectus and registration requirements pursuant to applicable regulations, including the Norwegian Securities Trading Act and ancillary regulations, are available.
The allocation of Offer Shares will be made at the sole discretion of the Board after input from the Manager. Allocation will be based on criteria such as (but not limited to), existing ownership in the Company, timeliness of the application, price leadership, relative order size, sector knowledge, investment history, perceived investor quality and investment horizon. The Board may, at its sole discretion, reject and/or reduce any applications. There is no guarantee that any applicant will be allocated Offer Shares. The allocation will be determined at the end of the bookbuilding period and final allocation will be made at the Board's sole discretion. Notification of allotment and payment instructions are expected to be issued to the applicants on or about 10 November 2021 through a notification to be issued by the Manager.
Settlement is expected to take place on or about 12 November 2021 on a delivery versus payment basis. The Offer Shares are expected to be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement expected to be entered into between certain existing shareholders, the Manager and the Company, in order to facilitate delivery of already listed shares in the Company to applicants (the "Share Lending Agreement"). The Offer Shares will thus be tradable from allocation. The share loan will be settled with new shares in the Company to be resolved issued by the Board pursuant to an authorization granted by the Company's annual general meeting held on 12 May 2021.
The Company reserves the right, at any time and for any reason, to cancel, and/or modify the terms of, the Private Placement prior to completion. Neither the Company nor the Manager will be liable for any losses incurred by applicants if the Private Placement is cancelled, irrespective of the reason for such cancellation.
The Board has considered the Private Placement in light of the equal treatment obligations under the Norwegian Public Limited Companies Act, the Norwegian Securities Trading Act, the rules on equal treatment under Oslo Rule Book II for companies listed on the Oslo Stock Exchange and the Oslo Stock Exchange's Guidelines on the rule of equal treatment, and deems that the proposed Private Placement is in compliance with these requirements. The Board holds the view that it will be in the common interest of the Company and its shareholders to raise equity through a private placement, in view of the current market conditions and the growth opportunities currently available to the Company. A private placement enables the Company to raise capital in an efficient manner, and the Private Placement is structured to ensure that a market-based subscription price is achieved. By structuring the equity raise as a private placement, the Company is expected to be in a position to raise capital at a better share price, at a lower cost and with significantly lower risk than in a rights issue.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Erling Svela, VP Finance on 9 November 2021 at 16:30 CET on behalf of the Company.
Redigert 10.11.2021 kl 08:06
Du må logge inn for å svare
-
«
- 1
- 2 »
tuja
09.11.2021 kl 16:39
5447
Like godt å bli ferdig med det.
Idex vil hente 200 millioner kroner
Idex, et norsk selskap som satser på fingeravtrykk-teknologi, vil gjøre en emisjon og hente inn 25 millioner amerikanske dollar i norske kroner gjennom aksjesalg. Det skriver selskapet i en børsmelding tirsdag.
Selskapet skriver i meldingen at pengene trengs frem til selskapet når såkalt "break-even"-inntjening, når inntekter og utgifter går i null.
Idex vil hente 200 millioner kroner
Idex, et norsk selskap som satser på fingeravtrykk-teknologi, vil gjøre en emisjon og hente inn 25 millioner amerikanske dollar i norske kroner gjennom aksjesalg. Det skriver selskapet i en børsmelding tirsdag.
Selskapet skriver i meldingen at pengene trengs frem til selskapet når såkalt "break-even"-inntjening, når inntekter og utgifter går i null.
Sente
09.11.2021 kl 16:47
5411
Enig, og Idex har ofte gått opp etter emisjonen, litt på grunn av den settes over sluttkurs og den fjerner en del usikkerhet.
Sente
09.11.2021 kl 16:55
5327
De ønsker 25MUSD og gikk på et 7,5MUSD tap sist kvartal. Det vil si de henter nok penger til litt over 3 kvartaler med dagens drift.
De har lov i henhold til general forsamling å printe ca. 91 millioner aksjer. Om de henter 25MUSD, så blir det ca. 2,3 kroner per aksje.
Håper de klarer en høyere pris og en lavere del aksjer.
Noen som ar lyst til å tippe på pris? Jeg tipper 3,0 kr :)
De har lov i henhold til general forsamling å printe ca. 91 millioner aksjer. Om de henter 25MUSD, så blir det ca. 2,3 kroner per aksje.
Håper de klarer en høyere pris og en lavere del aksjer.
Noen som ar lyst til å tippe på pris? Jeg tipper 3,0 kr :)
Kajtek
09.11.2021 kl 17:02
5468
https://finansavisen.no/nyheter/teknologi/2021/11/09/7769488/idex-vil-hente-200-millioner-i-emisjon
Jeg er ikke redd for emisjon. Ser bare mulighet til å kjøpe mer litt rimelig.
Jeg er ikke redd for emisjon. Ser bare mulighet til å kjøpe mer litt rimelig.
kaunis
09.11.2021 kl 17:43
5191
Her kastes ikke bort 25mill til en bokbuldingsprosess som går på skinner og kan være fulltegnet allerede. Selskapet legger altså opp til å oppnå en kurs så nær opptil dagens sluttkurs som mulig, og dette beroliger alle aksjonærer skulle en tro. Men uansett så vil kursen gå videre opp fremover, det er sjelden at en opplever en så profesjonell men dog rettet mot enkelte, emisjon, på et så riktig og viktig tidspunkt. Da seiler IDEX skuta med fulle tanker og når den er fri for bunkers, tar utviklingsturen slutt, for da går det videre på skinner i lang lang femtid. Her er det om å komme seg ombord sammen med det nye mannskapet, for å få være med helt fra starten ,på denne viktige reisen. God tur alle sammen.
tuja
09.11.2021 kl 17:56
5103
Uten tvil. Og dette poengterer selskapet klart og tydelig:
"Selskapet skriver i meldingen at pengene trengs frem til selskapet når såkalt "break-even"-inntjening, når inntekter og utgifter går i null. "
Neste trinn blir å være cash positiv, og deretter solid inntjening.
"Selskapet skriver i meldingen at pengene trengs frem til selskapet når såkalt "break-even"-inntjening, når inntekter og utgifter går i null. "
Neste trinn blir å være cash positiv, og deretter solid inntjening.
Sente
09.11.2021 kl 18:27
4938
mimsa skrev 2.80. For mange innsidere til at det blir 3kr.
Er det negativt at insidere blir med på emisjonen? 🤔
#InsiderKjøp
#InsiderKjøp
Sente
09.11.2021 kl 18:29
4922
Ikke at USA børsen har noe særlig volum, men IDBA gikk opp når meldingen kom, så noen tolket den positivt. (Eller manipulerer kursen for å at det skal se positivt ut)
kroif
09.11.2021 kl 18:42
4842
Insidere kjøper alt de kan, for nå er de siste hinderne fjernet, ordrene vil fortsette prikke inn med store volum.
Kursen har blitt holdt igjen etter nyheten pga emisjonen.
Alle større aksjonærer har spart kruttet til emisjon, sammen med en haug av insidere. Tipper emisjonen blir massivt overtegnet, og at kursen starter den laange oppturen
Kursen har blitt holdt igjen etter nyheten pga emisjonen.
Alle større aksjonærer har spart kruttet til emisjon, sammen med en haug av insidere. Tipper emisjonen blir massivt overtegnet, og at kursen starter den laange oppturen
suspekt
09.11.2021 kl 18:45
4818
Når en ser på nel, som bare overlever på emisjoner og kursen stiger hver dag, har ikke lagt frem ett kvartal med overskudd ennå, så kan det godt hende idex også får ett løft.
Vil ikke tjene penger før i slutten av 2022, men da kan det bli mye penger. Emisjon er ikke lån, det er jo bra.
Vil ikke tjene penger før i slutten av 2022, men da kan det bli mye penger. Emisjon er ikke lån, det er jo bra.
poki
09.11.2021 kl 18:45
4810
IDEMIA
Vill nån köpa aktier på 1 mille eller nån CFO skulle köpa för en halv miljon dollar om de inte har nåt i bagaget.
Snart kommer orden från Kina 🇨🇳 och IDEMIA och Zwipe och säkert vunnit någon kund med Infenion
3 månader leverans tid alla kommer beställa samtidigt 😛
Vill nån köpa aktier på 1 mille eller nån CFO skulle köpa för en halv miljon dollar om de inte har nåt i bagaget.
Snart kommer orden från Kina 🇨🇳 och IDEMIA och Zwipe och säkert vunnit någon kund med Infenion
3 månader leverans tid alla kommer beställa samtidigt 😛
poki
09.11.2021 kl 19:35
4612
IDEX Biometrics ASA American Depositary Shares (IDBA)
Nasdaq Listed
$29.71 (högst 31 Dollar :-)
+2.21 (+8.04%)
Nasdaq Listed
$29.71 (högst 31 Dollar :-)
+2.21 (+8.04%)
kaunis
09.11.2021 kl 19:47
4542
For shorterne er dette nesten selvskudd, de har to valg, kjøpe så fort som mulig, eller vente litt å håpe på å kunne selge den nok ned igjen. Men denne er kommet over det stadiet, da en får til nedsalg som hjelper på vanlig simpel manipulering av aksjekurser. Denne er kommet opp på et nivå hvor de fleste forstår og ser, at her er det en god fremtid for aksjen, og god, ja kjempegod stor god inntjeningen over mange år
iTRADER09
09.11.2021 kl 22:05
4160
Om Idex henter 25 MUSD så er det 9 måneder til neste emisjon. Den vil benytte en fullmakt fra generalforsamling 2022 til å øke antall aksjer med 10% til.
Fram til da er selskapet finansiert fram til break even, slik de har vært mange ganger de siste årene.
Det er bare ved siste Q før en emisjon at de ikke skal berges av inntekter.
Fram til da er selskapet finansiert fram til break even, slik de har vært mange ganger de siste årene.
Det er bare ved siste Q før en emisjon at de ikke skal berges av inntekter.
Redigert 09.11.2021 kl 22:06
Du må logge inn for å svare
tuja
09.11.2021 kl 22:11
4116
Du har vel fått med deg at sertifisering nå er i boks, og da er veien plutselig mye kortere til volumordrer og inntjening. Men det er vel ikke så viktig?
iTRADER09
09.11.2021 kl 22:19
4074
Om det er et marked så er det sikkert bra med sertifiseringen. Men idex har kun en ordre og den er uspesifisert på alle måter både volum og tidsperspektiv bortsett fra at de skal levere noe i Q1. FPC fikk den første ordrene på BPC for over et år siden og de er fortsatt på 100k volum. Den forrige sensoren til Idex hadde også sertifisering både av MC og CUP, men den solgte ikke i det hele tatt.
Skier
09.11.2021 kl 22:42
3958
Joda, basert på historikken har du absolutt grunn til å være skeptisk iTRADER09.Dog, det er nå markedet for biometriske kort starter. Faremomentet med å være for opptatt av hva som har skjedd så langt mht salg av kort med IDEX sin teknologi er at du ikke "ser skogen for bare trær" eller for å være enda litt mer flåsete "prøv å se litt lenger frem enn nesetippen" ;-)
Sølvbuen
09.11.2021 kl 23:04
3851
Jeg tror vi står foran en mega trend med Idex, men man må være tålmodig og sikte høyt, ellers bommer du.
DIGITAL VALUTA: Bank of England, sentralbanken i Storbritannia, skal vurdere å innføre en digital valuta.
Kina sier det samme og det er mange land nå som vurderer dette. Idex er i posisjon. Hvem andre ?
Pust med magen og sitt rolig. Løp & kjøp mer !
DIGITAL VALUTA: Bank of England, sentralbanken i Storbritannia, skal vurdere å innføre en digital valuta.
Kina sier det samme og det er mange land nå som vurderer dette. Idex er i posisjon. Hvem andre ?
Pust med magen og sitt rolig. Løp & kjøp mer !
iTRADER09
09.11.2021 kl 23:09
3826
Min skepsis nå er ikke spesielt rettet mot Idex og Idex sin tvilsomme historie, men mot BPC generelt. Betalingskort er et vanskelig marked og svært kostnads-sensitivt. Se hvor lang tid det tok fra magnetstripe til Chip and Pin, enda det var en dramatisk sikkerhetsforbedring og en mye lavere prisdifferanse. Jeg tror også det er tvil hos utstederne om dette har en framtid. Både utstedere og kortselskapene satser store penger på hel-digitale løsninger uten plast fordi de tror det er det som er fremtiden og ikke minst adresserer det "card not present" transaksjoner som er ansvarlig for mesteparten av "kredittkort" svindelen idag. De har satset bare noen småpenger på BPC, det meste av det er finansiert av to skandinaviske sensorleverandører og av kort-produsenter som står i fare for å bli irrelevante av hel-digitale løsninger. Jeg har også liten tro på Kina haussingen. Markedsleder innen kapasitive fingeravtrykk sensorer er et kinesisk selskap som sikkert er godt "connected" i Kina og de sitter helt rolig og gjør absolutt ingenting i forhold til BPC eller "hardware wallet". Jeg nekter å tro at det skyldes at de er så dumme at de ikke vet hva som foregår i sin egen bakgård.
Redigert 09.11.2021 kl 23:11
Du må logge inn for å svare
Sente
10.11.2021 kl 08:01
3471
Oslo, 10 November 2021. Reference is made to the press release from IDEX
Biometrics ASA ("IDEX" or the "Company") published on 9 November 2021 regarding
a contemplated private placement (the "Private Placement").
IDEX is pleased to announce that the Private Placement has been successfully
completed and will raise gross proceeds to the Company of approx. USD 30
million, equivalent to NOK 256 million, through the issue of 89,777,824 new
shares (the "Offer Shares") at a price of NOK 2.85 per Offer Share (the "Offer
Price").
The Private Placement attracted strong interest from Norwegian, Nordic and
international high-quality institutional investors and was multiple times
oversubscribed. In light of the strong demand for the Company's Offer Shares in
the bookbuilding for the Private Placement, the Company decided to increase the
offering size from up to the NOK equivalent of USD 25 million to up to the NOK
equivalent of USD 30 million.
The Company intends to use the net proceeds from the Private Placement to cover
the forecasted cash requirements until the point of cashflow break even as well
as for general corporate purposes.
Allocation to investors will be communicated on 10 November 2021. The Private
Placement will be settled by the Manager on a delivery-versus-payment basis on
12 November 2021. Offer Shares in the Private Placement will be settled with
existing and unencumbered shares in the Company, pursuant to a share lending
agreement expected to be entered into between the Manager, certain existing
shareholders and the Company. The Offer Shares will thus be tradable from
allocation. The share loan will be settled with a corresponding number of new
shares in the Company which the board of directors of the Company today resolved
to issue at the Offer Price pursuant to an authorization granted by the
Company's annual general meeting held on 12 May 2021.
As set out in the Company's announcement on 9 November 2021, the Board has
considered the Private Placement in light of the equal treatment obligations
under applicable laws and regulations and found that the Private Placement, as
undertaken, is in compliance with these requirements. The Board has therefore
concluded that there will not be a subsequent offering.
Following registration of the share capital increase pertaining to the issue of
the Offer Shares in the Norwegian Register of Business Enterprises, the Company
will have a share capital of NOK 151,392,751.80, divided into 1,009,285,012
shares, each with a nominal value of NOK 0.15
Biometrics ASA ("IDEX" or the "Company") published on 9 November 2021 regarding
a contemplated private placement (the "Private Placement").
IDEX is pleased to announce that the Private Placement has been successfully
completed and will raise gross proceeds to the Company of approx. USD 30
million, equivalent to NOK 256 million, through the issue of 89,777,824 new
shares (the "Offer Shares") at a price of NOK 2.85 per Offer Share (the "Offer
Price").
The Private Placement attracted strong interest from Norwegian, Nordic and
international high-quality institutional investors and was multiple times
oversubscribed. In light of the strong demand for the Company's Offer Shares in
the bookbuilding for the Private Placement, the Company decided to increase the
offering size from up to the NOK equivalent of USD 25 million to up to the NOK
equivalent of USD 30 million.
The Company intends to use the net proceeds from the Private Placement to cover
the forecasted cash requirements until the point of cashflow break even as well
as for general corporate purposes.
Allocation to investors will be communicated on 10 November 2021. The Private
Placement will be settled by the Manager on a delivery-versus-payment basis on
12 November 2021. Offer Shares in the Private Placement will be settled with
existing and unencumbered shares in the Company, pursuant to a share lending
agreement expected to be entered into between the Manager, certain existing
shareholders and the Company. The Offer Shares will thus be tradable from
allocation. The share loan will be settled with a corresponding number of new
shares in the Company which the board of directors of the Company today resolved
to issue at the Offer Price pursuant to an authorization granted by the
Company's annual general meeting held on 12 May 2021.
As set out in the Company's announcement on 9 November 2021, the Board has
considered the Private Placement in light of the equal treatment obligations
under applicable laws and regulations and found that the Private Placement, as
undertaken, is in compliance with these requirements. The Board has therefore
concluded that there will not be a subsequent offering.
Following registration of the share capital increase pertaining to the issue of
the Offer Shares in the Norwegian Register of Business Enterprises, the Company
will have a share capital of NOK 151,392,751.80, divided into 1,009,285,012
shares, each with a nominal value of NOK 0.15
Redigert 10.11.2021 kl 08:02
Du må logge inn for å svare
Overtegnet! Dette blir bra, fin signal.
kroif
10.11.2021 kl 08:19
3338
So far, so good.
Håper de som ikke fikk fullpott i emisjonen kjøper resten i markedet;-)
Med "multipel times" blir det veldig mange aksjer, var det 90mill aksjer som ble tegnet?
Shorterne bør ihvertfall ta action.
Håper de som ikke fikk fullpott i emisjonen kjøper resten i markedet;-)
Med "multipel times" blir det veldig mange aksjer, var det 90mill aksjer som ble tegnet?
Shorterne bør ihvertfall ta action.
tuja
10.11.2021 kl 08:21
3319
Hørte ryktene om 2,85 og overtegning i går kveld. Supert at det stemte. Sterkt signal.
:)
:)
Føre var
10.11.2021 kl 08:23
3288
«Multiple times oversubscribed»
Kunne de lett hente en milliard da muligens?
Her kan det bli liv, flere som vil inn virker det som:)
Kunne de lett hente en milliard da muligens?
Her kan det bli liv, flere som vil inn virker det som:)
investor tom
10.11.2021 kl 09:20
3002
Idex hentet det de Max kunne hente i hht GF beslutning fra mai 2021. Spørsmålet nå er om Idex sine kunder vil lykkes i sitt salg av sine produkter inkludert Idex sitt produkt. Har vært mange positive meldinger fra selskapet. Ser veldig positivt på at de sentrale og best informerte i ledergruppa går «tungt» inn i fht sin egen lommebok. Kursen åpner positivt, men vil selvfølgelig svinge, som alltid i IDEX. Ha tålmodighet og så ser vi hva kursen er i mars 2022.
tuja
10.11.2021 kl 09:25
2957
Blir vel en tur innom emi-kurs, som vanlig. Men, ingenting er skrevet i stein.
Kajtek
10.11.2021 kl 09:30
2908
Har noen av små investorer fått mulighet til å være med på emisjonen?
kommer flere meldinger snart om inside handler.
kommer flere meldinger snart om inside handler.
Sente
10.11.2021 kl 09:39
2834
Definer små investorer. :)
The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000
Vil ikke si små investorer har 1 mill liggende til å hive seg på denne emisjonen. De har nok gått gjennom aksje listene og tilbydd til dem øverste på dem, samt kanskje noen som har flagget interesse.
The minimum application and allocation amount in the Private Placement will be the NOK equivalent of EUR 100,000
Vil ikke si små investorer har 1 mill liggende til å hive seg på denne emisjonen. De har nok gått gjennom aksje listene og tilbydd til dem øverste på dem, samt kanskje noen som har flagget interesse.
Sente
10.11.2021 kl 18:37
2443
Mandatory notice of trade in IDEX 9 November 2021
Reference is made to IDEX Biometrics ASA’s private placement on 9 November 2021 of 89,777,824 shares at NOK 2.85 per share. Allocation has been communicated to investors today,
IDEX discloses transactions by the following primary insiders in IDEX shares, ISIN NO0003070609: Primary insiders were allocated, and have thus subscribed for, the following number of shares.
– Board member Annika Olsson: 52,631 shares at NOK 2.85 per share.
– CEO Vince Graziani: 149,473 shares at NOK 2.85 per share.
– CFO Jamie Simms: 1,494,736 shares at NOK 2.85 per share.
– CCO Catharina Eklof: 89,684 shares at NOK 2.85 per share.
Ikke akkurat overraskende. :)
Reference is made to IDEX Biometrics ASA’s private placement on 9 November 2021 of 89,777,824 shares at NOK 2.85 per share. Allocation has been communicated to investors today,
IDEX discloses transactions by the following primary insiders in IDEX shares, ISIN NO0003070609: Primary insiders were allocated, and have thus subscribed for, the following number of shares.
– Board member Annika Olsson: 52,631 shares at NOK 2.85 per share.
– CEO Vince Graziani: 149,473 shares at NOK 2.85 per share.
– CFO Jamie Simms: 1,494,736 shares at NOK 2.85 per share.
– CCO Catharina Eklof: 89,684 shares at NOK 2.85 per share.
Ikke akkurat overraskende. :)
Redigert 10.11.2021 kl 18:40
Du må logge inn for å svare
Nok til at de har klart å utvikle et salgbart produkt!
Mer interessant: hvor mye har du tapt på Idex?
Mer interessant: hvor mye har du tapt på Idex?
-
«
- 1
- 2 »